Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 66

Sort by

Sort Order Select

Journal Articles

Natural History of Skeletal Related Events in Patients with Multiple Myeloma Who Received First- and Second- Line Therapy with Novel Agents: Results from a Single Center Analysis in 620 Patients

Evangelos Terpos, MD PhD, Nikolaos Kanellias, MD, Eftathios Kastritis, Maria Gavriatopoulou, MD, Vassilis Koutoulidis, MD, Ioannis Ntanasis-Stathopoulos, MD, Aristea-Maria Papanota, MD, Despina Fotiou, MD, Magdalini Migkou, MD, Evangelos Eleutherakis-Papaiakovou, MD, Panagiotis Malandrakis, MD, Tina Bagratuni, PhD, Maria Roussou, MD, Lia A. Moulopoulos, MD, Meletios A. Dimopoulos, MD

Blood (2019) 134 (Supplement_1): 4326.

https://doi.org/10.1182/blood-2019-123606

Published: 2019

Journal Articles

Real Life Use of Imaging in the Management of Newly Diagnosed Patients with Myeloma- Practical Perspectives from a UK Hospital

Ke Xu, MD, Lucy Fowkes, Fenella Willis, Yasmin Reyal

Blood (2019) 134 (Supplement_1): 5513.

https://doi.org/10.1182/blood-2019-121504

Published: 2019

Journal Articles

Cases of Extra- Medullary Myeloma Presenting As Liver Infiltrates: A Single Community Hospital Experience

Yang Yang, Sorab Gupta, MD, Rashmika Potdar, MBBS, Mark S Morginstin, DO, Gabor Varadi, MD

Blood (2018) 132 (Supplement 1): 5644.

https://doi.org/10.1182/blood-2018-99-117720

Published: 2018

Journal Articles

Impact of HIV on Clinical Presentation and Outcomes of Individuals with Multiple Myeloma

Smith Giri, MBBS, Ellice Y. Wong, MD, Michal Rose, MD, Roxanne Wadia, MD, Lesley S. Park, PhD MPH, Amy C. Justice, MD PhD, Natalia Neparidze, MD

Blood (2018) 132 (Supplement 1): 3162.

https://doi.org/10.1182/blood-2018-99-115633

Published: 2018

Journal Articles

Relationship between Bone Marrow PD-1 and PD-L1 Expression and the Presence of Osteolytic Bone Disease in Multiple Myeloma Patients

Federica Costa, MS, Marina Bolzoni, PhD, Rosanna Vescovini, PhD, Fabrizio Accardi, MD, Anna Benedetta Dalla Palma, MD, Federica De Luca, PhD, Valentina Marchica, MS, Denise Toscani, PhD, Emanuela Vicario, MS, Paola Storti, PhD, Franco Aversa, MD, Nicola Giuliani, MD PhD

Blood (2018) 132 (Supplement 1): 3183.

https://doi.org/10.1182/blood-2018-99-118200

Published: 2018

Journal Articles

Diagnostic Relevance of 18F-FDG PET/CT in Newly Diagnosed Patients with Monoclonal Gammopathy of Undetermined Significance (MGUS) : Single- Center Experience

Viera Sandecka, MD PhD, Ludek Pour, MD, Zdenek Adam, Prof, MD CSc, Martin Stork, MD, Marta Krejci, Prof, MD PhD, Jana Michalcova, MD, Zdenek Kral, MD CSc, Sabina Sevcikova, PhD, Zdeněk Řehák, MD PhD, Renata Koukalova, MD

Blood (2018) 132 (Supplement 1): 1913.

https://doi.org/10.1182/blood-2018-99-111094

Published: 2018

Journal Articles

Systemic Versus Local Treatment in Patients with Multiple Myeloma and a Single Lesion in Whole Body Imaging

Sandra Sauer, MD, Anna Bergmann, Barbara Wagner, Thomas Hielscher, PhD, Carsten Müller-Tidow, Hartmut Goldschmidt, MD, Jens Hillengass, MD

Blood (2017) 130 (Supplement 1): 3092.

https://doi.org/10.1182/blood.V130.Suppl_1.3092.3092

Published: 2017

Journal Articles

Surveillance Functional Imaging Has Limited Role in Solitary Plasmacytomas: International Multi-Centre Study of Clinical Outcomes

Faye A Sharpley, MBBChir, MA, MRCP, MSc BA, Pedro Neffa, Fotis Panitsas, Jaimal Kothari, David Cutter, Roberta Shcolnik Szor, Manil Subesinghe, MBBS, MRCP, FRCR., Gracia Martinez, MD, Vanderson Rocha, MD PhD, Karthik Ramasamy

Blood (2017) 130 (Supplement 1): 5379.

https://doi.org/10.1182/blood.V130.Suppl_1.5379.5379

Published: 2017

Journal Articles

Findings of Whole Body Computed Tomography Compared to Conventional Skeletal Survey in Patients with Monoclonal Plasma Cell Disorders - a Study of the International Myeloma Working Group

Blood (2016) 128 (22): 4468.

https://doi.org/10.1182/blood.V128.22.4468.4468

Published: 2016

Journal Articles

Hevylite and Freelite Normalisation Is a Surrogate Marker for MRD Negativity Post-ASCT

Lauren Campbell, Fotios Panitsas, Supratik Basu, Francis Anyanu, Sophie Lee, Berne Ferry, Karthik Ramasamy

Blood (2016) 128 (22): 4633.

https://doi.org/10.1182/blood.V128.22.4633.4633

Published: 2016

Journal Articles

Increased Risk of Sternal Complications in Patients with Plasma Cell Dyscrasias (PCDs) Undergoing Coronary Artery Bypass Graft (CABG)

Malini M Patel, MD, Shams B Bufalino, MD, Anai N Kothari, MD, Paul C Kuo, MD, Sucha Nand, MD

Blood (2015) 126 (23): 5319.

https://doi.org/10.1182/blood.V126.23.5319.5319

Published: 2015

Journal Articles

Serum Free Light Chain Assays in the Risk Stratification of Monoclonal Gammopathy of Undetermined Significance: Results from a Pharmacoeconomic Evaluation

Guy Pratt, MDFRCP FRCPath, Holly Cranmer, BSc, Christine Almond, MSC, MMath, Stephen Harding, PhD, Dale John Powner, PhD, Richard Geir Hughes, DPhil, Mark Cook, PhD MBChb

Blood (2015) 126 (23): 3258.

https://doi.org/10.1182/blood.V126.23.3258.3258

Published: 2015

Journal Articles

Significance of Bone Marrow Plasma Cell Percentage in Patients with Monoclonal Gammopathy of Unknown Significance Developing Multiple Myeloma

Mona L Vekaria, MD, Bharat Rao, MD, Philip Kuriakose, MD

Blood (2014) 124 (21): 5688.

https://doi.org/10.1182/blood.V124.21.5688.5688

Published: 2014

Journal Articles

Comparison of Assesment of Imaging Response with Magnetic Resonance (MR) and 18 fdg-PET/TC in Multiple Myeloma (MM). Single Centre Experience

Adrian Alegre, Beatriz Aguado, Miriam González-Pardo, Evelyn Acuña, Álvaro Arriero, Maria Aragonés, Lourdes Del Campo, S Llorente, Elena Ocón, Nieves Gómez León

Blood (2014) 124 (21): 5707.

https://doi.org/10.1182/blood.V124.21.5707.5707

Published: 2014

Journal Articles

Phase II Trial Of Initial Safety and Toxicity Prior To The Phase III Trial Of Lenalidomide Versus Observation Alone In Patients With Asymptomatic High-Risk Smoldering Multiple Myeloma (E3A06): A Trial Coordinated By The Eastern Cooperative Oncology Group

Sagar Lonial, M.D., Susanna Jacobus, Matthias Weiss, MD, PhD, Rafael Fonseca, MD, Madhav V. Dhodapkar, MD, S. Vincent Rajkumar, MD

Blood (2013) 122 (21): 3174.

https://doi.org/10.1182/blood.V122.21.3174.3174

Published: 2013

Journal Articles

Skeletal-Related Events In Patients With Multiple Myeloma In The Era Of Novel Agents: Low Incidence Of Pathological Fractures After Treatment

Evangelos Terpos, Nikolaos Kanellias, Lia A Moulopoulos, Dimitrios Christoulas, Andreas Koureas, Tina Bagratuni, Vasilios Koutoulidis, Efstathios Kastritis, Meletios A. Dimopoulos, MD

Blood (2013) 122 (21): 3090.

https://doi.org/10.1182/blood.V122.21.3090.3090

Published: 2013

Journal Articles

Effect Of Advanced Lytic Bone Lesions On Peripheral Stem Cell Mobilization In Patients With Multiple Myeloma

Sung-Hoon Jung, MD, Jae-Sook Ahn, MD, PhD, Deok-Hwan Yang, MD, PhD, Yeo-Kyeoung Kim, MD, PhD, Hyeoung-Joon Kim, MD, PhD, Je-Jung Lee, MD, PhD

Blood (2013) 122 (21): 3276.

https://doi.org/10.1182/blood.V122.21.3276.3276

Published: 2013

Journal Articles

Immunophenotypic Response After Allografting In Multiple Myeloma

Luisa Giaccone, MD, Lucia Brunello, Roberto Passera, Moreno Festuccia, MD, Milena Gilestro, Enrico Maffini, Federica Ferrando, Mario Boccadoro, MD, Paola Omedè, MD, Benedetto Bruno

Blood (2013) 122 (21): 3371.

https://doi.org/10.1182/blood.V122.21.3371.3371

Published: 2013

Journal Articles

Bone Marrow Aspirate Can Be Avoided in Low-Risk MGUS Patients

Silvia Mangiacavalli, Federica Cocito, MD, Lara Pochintesta, Cristiana Pascutto, Alessandra Pompa, Mario Cazzola, Alessandro Corso

Blood (2012) 120 (21): 3997.

https://doi.org/10.1182/blood.V120.21.3997.3997

Published: 2012

Journal Articles

Serum C-Terminal Telopeptide Maintains Its Correlation with Bone Disease in Myeloma Patients Even Under Treatment with Bisphosphonates

Lara Pochintesta, Silvia Mangiacavalli, MD, Federica Cocito, MD, Cristiana Pascutto, Alessandra Pompa, Mario Cazzola, Alessandro Corso

Blood (2012) 120 (21): 4003.

https://doi.org/10.1182/blood.V120.21.4003.4003

Published: 2012

NARROW

Natural History of Skeletal Related Events in Patients with Multiple Myeloma Who Received First- and Second- Line Therapy with Novel Agents: Results from a Single Center Analysis in 620 Patients

Real Life Use of Imaging in the Management of Newly Diagnosed Patients with Myeloma- Practical Perspectives from a UK Hospital

Cases of Extra- Medullary Myeloma Presenting As Liver Infiltrates: A Single Community Hospital Experience

Impact of HIV on Clinical Presentation and Outcomes of Individuals with Multiple Myeloma

Relationship between Bone Marrow PD-1 and PD-L1 Expression and the Presence of Osteolytic Bone Disease in Multiple Myeloma Patients

Diagnostic Relevance of 18F-FDG PET/CT in Newly Diagnosed Patients with Monoclonal Gammopathy of Undetermined Significance (MGUS) : Single- Center Experience

Systemic Versus Local Treatment in Patients with Multiple Myeloma and a Single Lesion in Whole Body Imaging

Surveillance Functional Imaging Has Limited Role in Solitary Plasmacytomas: International Multi-Centre Study of Clinical Outcomes

Findings of Whole Body Computed Tomography Compared to Conventional Skeletal Survey in Patients with Monoclonal Plasma Cell Disorders - a Study of the International Myeloma Working Group

Hevylite and Freelite Normalisation Is a Surrogate Marker for MRD Negativity Post-ASCT

Increased Risk of Sternal Complications in Patients with Plasma Cell Dyscrasias (PCDs) Undergoing Coronary Artery Bypass Graft (CABG)

Serum Free Light Chain Assays in the Risk Stratification of Monoclonal Gammopathy of Undetermined Significance: Results from a Pharmacoeconomic Evaluation

Significance of Bone Marrow Plasma Cell Percentage in Patients with Monoclonal Gammopathy of Unknown Significance Developing Multiple Myeloma

Comparison of Assesment of Imaging Response with Magnetic Resonance (MR) and 18 fdg-PET/TC in Multiple Myeloma (MM). Single Centre Experience

Phase II Trial Of Initial Safety and Toxicity Prior To The Phase III Trial Of Lenalidomide Versus Observation Alone In Patients With Asymptomatic High-Risk Smoldering Multiple Myeloma (E3A06): A Trial Coordinated By The Eastern Cooperative Oncology Group

Skeletal-Related Events In Patients With Multiple Myeloma In The Era Of Novel Agents: Low Incidence Of Pathological Fractures After Treatment

Effect Of Advanced Lytic Bone Lesions On Peripheral Stem Cell Mobilization In Patients With Multiple Myeloma

Immunophenotypic Response After Allografting In Multiple Myeloma

Bone Marrow Aspirate Can Be Avoided in Low-Risk MGUS Patients

Serum C-Terminal Telopeptide Maintains Its Correlation with Bone Disease in Myeloma Patients Even Under Treatment with Bisphosphonates

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only